Summary
To determine the epidemiological pattern and some clinicopathological features of Hodgkin's disease in Hungary, the data of 233 consecutive patients with the disease from seven counties, diagnosed between January 1983 and July 1987, were analysed on the basis of data from four cancer centers. Large variations were noted in incidence rates between the different regions of Hungary. The epidemiological pattern seems to vary from those reported in developed and developing countries. A sharp rise in the incidence of Hodgkin's disease occurred at the end of the second decade of patients' lives. More of our Hodgkin's patients are at advanced clinical stages, with systemic symptoms and a histological type of mixed cellularity, at the time of diagnosis, than in the western hemisphere. On the average, there is a 6-month period between the appearance of the first sign or symptom and the diagnosis. There is a lack of data outlining the epidemiological differences in the pattern of Central Europa. The aim of this study is to supply data for the etiopathogenetic research of Hodgkin's disease, as there is an important task to improve the unfavourable home situation, and to strive for earlier diagnosis in this disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- LP:
-
lymphocytic predominance
- NS:
-
nodular sclerosis
- MC:
-
mixed cellularity
- LD:
-
lymphocytic depletion
References
Alderson MR, Nayak R (1972) Epidemiology of Hodgkin's disease. J Chronic Dis 25:253–259
Berard CW, Thomas LB, Axtell LM, Kruse M, Newell G, Kagan R (1971) The relationship of histopathological subtype to clinical stage of Hodgkin's disease at diagnosis. Cancer Res 31:1776–1785
Bernard SM, Cartwright BA, Durwin CM, Richards IDG, O'Brien C, Bird CC (1987) Hodgkin's disease: case control epidemiologic study in Yorkshire. Br J Cancer 55:85–90
Buehler SK, Firme F, Fodor G, Fraser GR, Marshall WH, Vaze F (1975) Common variable immunodeficiency. Hodgkin's disease and other malignancies in a Newfoundland family. Lancet 1:195–196
Butler JJ (1971) Relationship of histological findings to survival in Hodgkin's disease. Cancer Res 31:1770–1775
Carbone PP, Kaplan HS, Mushoff K, Smithers VW, Tubiana M (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Res 31:1860–1861
Colby TV, Hoppe RT, Warnke RA (1981) Hodgkin's disease. A clinicopathologic study of 659 cases. Cancer 49:1848–1858
Cole P (1972) Epidemiology of Hodgkin's disease. JAMA 222:1636–1639
Correa P, O'Conor GT (1971) Epidemiologic patterns of Hodgkin's disease. Int J Cancer 8:192–201
Dienshaw KA, Advani SH, Gopal R, Nair CN, Talvarkar GV, Gangadharan P, Desai B (1984) Management of Hodgkin's disease in western India. Cancer 54:1276–1282
Dienstbier Z, Foltynova V, Hermanska Z, Citavy M, Beska F, Cerny J, Hynek J, Koutna J, Machacek J, Zemanova K, Soudla V, Svojgrova M (1986) Prognostic factors in Hodgkin's disease. Neoplasma 33:731–735
Dorfman RF (1971) Relationship of histology to site in Hodgkin's disease. Cancer Res 31:1786–1793
Gutensohn NM (1982) Social class and age at diagnosis of Hodgkin's disease. New epidemiologic evidence for the “two disease hypothesis”. Cancer Treat Rep 66:689–695
Haybittle JL, Easterling MJ, Bennett MH (1985) Review of British National Lymphoma Investigation Studies of Hodgkin's disease and development of prognostic index. Lancet 1:967–995
Hirayama T, Waterhouse JAH, Fraumeni JF (1980) Cancer risks by site. UICC Technical Report Series, vol 41, Geneva, 198–203
Kennedy BL, Loeb V, Peterson VM, Donegan WL, Natarajan N, Mettlin C (1985) National survey of patterns of care for Hodgkin's disease. Cancer 56:2547–2556
Kerzin-Storrar L, Faed MJW, MacGillivray JB, Smith PG (1983) Incidence of familial Hodgkin's disease. Br J Cancer 47:707–712
Lukes RJ, Craver LF, Hall TC, Rappaport H, Ruben P (1966) Report of the nomenclature committee. Cancer Res 26:1311
MacMahon B (1966) Epidemiology of Hodgkin's disease. Cancer Res 26:1189–1200
MacMahon B (1971) Epidemiological consideration in staging of Hodgkin's disease. Cancer Res 31:1854–1857
Mughal TT, Robinson WA, Padmas MA (1985) Adult Hodgkin's disease in Saudi Arabia. Eur J Surg Oncol 11:41–45
Muir C, Waterhouse J, Mack T, Powell J, Wehlan S (1987) Cancer incidence in five continents, vol. V. IARC, Lyon
Rosenberg SA, Kaplan HS (1985) The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease 1962–1981. Int J Radiol Oncol 11:5–17
Ruuskanen O, Vanka-Perttula T, Kouvalainen K (1971) Tonsillectomy, appendectomy and Hodgkin's disease. Lancet 1:1127–1128
Shanta V, Sastri DVLN, Sagar TG, Sasikala K, Krishnamurthi S (1982) A review of Hodgkin's disease at Cancer Institute, Madras. Clin Oncol 8:5–15
Teillet F, Botron M, Bernard J (1971) A reappraisal of clinical and biologic signs in staging of Hodgkin's disease. Cancer Res 31:1723–1729
Tubiana M, Attie E, Flamant R, Gerard-Marchant R, Hayat M (1971) Prognostic factors in 454 cases of Hodgkin's disease. Cancer Res 31:1801–1810
Wedelin C, Björkholm M, Johansson B, Mellstedt H (1984) Clinical and laboratory findings in untreated patients with Hodgkin's disease with special reference to age. Med Oncol Tumor Pharmacother 1:33–41
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berényi, E., Szegedi, G., Szabó, K. et al. Comprehensive epidemiological and clinicopathological survey of Hodgkin's disease in Hungary. J Cancer Res Clin Oncol 116, 87–93 (1990). https://doi.org/10.1007/BF01612645
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01612645